nodes	percent_of_prediction	percent_of_DWPC	metapath
Bismuth Subsalicylate—PTGS2—coronary artery disease	0.17	0.529	CbGaD
Bismuth Subsalicylate—ALB—coronary artery disease	0.151	0.471	CbGaD
Bismuth Subsalicylate—PTGS2—Acetylsalicylic acid—coronary artery disease	0.0595	0.155	CbGbCtD
Bismuth Subsalicylate—ALB—Pitavastatin—coronary artery disease	0.0522	0.136	CbGbCtD
Bismuth Subsalicylate—ALB—Valsartan—coronary artery disease	0.0508	0.132	CbGbCtD
Bismuth Subsalicylate—PTGS1—Acetylsalicylic acid—coronary artery disease	0.0502	0.131	CbGbCtD
Bismuth Subsalicylate—ALB—Rosuvastatin—coronary artery disease	0.0385	0.1	CbGbCtD
Bismuth Subsalicylate—ALB—Acetylsalicylic acid—coronary artery disease	0.0375	0.0975	CbGbCtD
Bismuth Subsalicylate—ALB—Captopril—coronary artery disease	0.0371	0.0963	CbGbCtD
Bismuth Subsalicylate—ALB—Furosemide—coronary artery disease	0.0298	0.0774	CbGbCtD
Bismuth Subsalicylate—ALB—Losartan—coronary artery disease	0.0292	0.0758	CbGbCtD
Bismuth Subsalicylate—TF—heart—coronary artery disease	0.000212	0.12	CbGeAlD
Bismuth Subsalicylate—TF—cardiovascular system—coronary artery disease	0.0002	0.113	CbGeAlD
Bismuth Subsalicylate—Dyspepsia—Telmisartan—coronary artery disease	0.000173	0.0011	CcSEcCtD
Bismuth Subsalicylate—Infection—Losartan—coronary artery disease	0.000173	0.0011	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Lovastatin—coronary artery disease	0.000173	0.0011	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Furosemide—coronary artery disease	0.000172	0.00109	CcSEcCtD
Bismuth Subsalicylate—Constipation—Trandolapril—coronary artery disease	0.000171	0.00109	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Valsartan—coronary artery disease	0.000171	0.00109	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Telmisartan—coronary artery disease	0.000171	0.00109	CcSEcCtD
Bismuth Subsalicylate—Nausea—Rosuvastatin—coronary artery disease	0.000171	0.00109	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Fenofibrate—coronary artery disease	0.000171	0.00109	CcSEcCtD
Bismuth Subsalicylate—Constipation—Enalapril—coronary artery disease	0.000171	0.00108	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Olmesartan—coronary artery disease	0.00017	0.00108	CcSEcCtD
Bismuth Subsalicylate—PTGS1—artery—coronary artery disease	0.00017	0.0964	CbGeAlD
Bismuth Subsalicylate—Somnolence—Captopril—coronary artery disease	0.00017	0.00108	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Pravastatin—coronary artery disease	0.00017	0.00108	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Olmesartan—coronary artery disease	0.00017	0.00108	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Ezetimibe—coronary artery disease	0.000169	0.00108	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Captopril—coronary artery disease	0.000169	0.00107	CcSEcCtD
Bismuth Subsalicylate—Pain—Telmisartan—coronary artery disease	0.000168	0.00107	CcSEcCtD
Bismuth Subsalicylate—Constipation—Telmisartan—coronary artery disease	0.000168	0.00107	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Clopidogrel—coronary artery disease	0.000168	0.00107	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Lovastatin—coronary artery disease	0.000167	0.00106	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Niacin—coronary artery disease	0.000167	0.00106	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Captopril—coronary artery disease	0.000166	0.00106	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Losartan—coronary artery disease	0.000166	0.00106	CcSEcCtD
Bismuth Subsalicylate—Nausea—Acetylsalicylic acid—coronary artery disease	0.000166	0.00106	CcSEcCtD
Bismuth Subsalicylate—Erythema—Lisinopril—coronary artery disease	0.000166	0.00105	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Eplerenone—coronary artery disease	0.000166	0.00105	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Niacin—coronary artery disease	0.000166	0.00105	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Fenofibrate—coronary artery disease	0.000165	0.00105	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Perindopril—coronary artery disease	0.000165	0.00105	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Trandolapril—coronary artery disease	0.000165	0.00105	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Enalapril—coronary artery disease	0.000164	0.00104	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Pravastatin—coronary artery disease	0.000164	0.00104	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Ezetimibe—coronary artery disease	0.000164	0.00104	CcSEcCtD
Bismuth Subsalicylate—Constipation—Captopril—coronary artery disease	0.000164	0.00104	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Perindopril—coronary artery disease	0.000164	0.00104	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Pravastatin—coronary artery disease	0.000163	0.00104	CcSEcCtD
Bismuth Subsalicylate—PTGS2—artery—coronary artery disease	0.000163	0.0921	CbGeAlD
Bismuth Subsalicylate—Dysgeusia—Lisinopril—coronary artery disease	0.000163	0.00103	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Clopidogrel—coronary artery disease	0.000162	0.00103	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Telmisartan—coronary artery disease	0.000162	0.00103	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Perindopril—coronary artery disease	0.000162	0.00103	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Simvastatin—coronary artery disease	0.000162	0.00103	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Lovastatin—coronary artery disease	0.000161	0.00102	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Furosemide—coronary artery disease	0.000161	0.00102	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Eplerenone—coronary artery disease	0.00016	0.00102	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Trandolapril—coronary artery disease	0.000159	0.00101	CcSEcCtD
Bismuth Subsalicylate—Constipation—Perindopril—coronary artery disease	0.000159	0.00101	CcSEcCtD
Bismuth Subsalicylate—Pain—Perindopril—coronary artery disease	0.000159	0.00101	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Fenofibrate—coronary artery disease	0.000159	0.00101	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Enalapril—coronary artery disease	0.000159	0.00101	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Trandolapril—coronary artery disease	0.000158	0.00101	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Ezetimibe—coronary artery disease	0.000158	0.001	CcSEcCtD
Bismuth Subsalicylate—TF—blood—coronary artery disease	0.000158	0.0893	CbGeAlD
Bismuth Subsalicylate—Body temperature increased—Enalapril—coronary artery disease	0.000158	0.001	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Captopril—coronary artery disease	0.000158	0.001	CcSEcCtD
Bismuth Subsalicylate—Rash—Fenofibrate—coronary artery disease	0.000158	0.001	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Fenofibrate—coronary artery disease	0.000157	0.001	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Furosemide—coronary artery disease	0.000157	0.000997	CcSEcCtD
Bismuth Subsalicylate—Headache—Fenofibrate—coronary artery disease	0.000157	0.000994	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Telmisartan—coronary artery disease	0.000156	0.000993	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Clopidogrel—coronary artery disease	0.000156	0.000992	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Simvastatin—coronary artery disease	0.000156	0.000992	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Telmisartan—coronary artery disease	0.000156	0.000988	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Lovastatin—coronary artery disease	0.000155	0.000985	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Losartan—coronary artery disease	0.000155	0.000984	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Eplerenone—coronary artery disease	0.000155	0.000984	CcSEcCtD
Bismuth Subsalicylate—Rash—Clopidogrel—coronary artery disease	0.000155	0.000983	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Clopidogrel—coronary artery disease	0.000155	0.000983	CcSEcCtD
Bismuth Subsalicylate—Pain—Furosemide—coronary artery disease	0.000155	0.000981	CcSEcCtD
Bismuth Subsalicylate—Constipation—Furosemide—coronary artery disease	0.000155	0.000981	CcSEcCtD
Bismuth Subsalicylate—Headache—Clopidogrel—coronary artery disease	0.000154	0.000977	CcSEcCtD
Bismuth Subsalicylate—Rash—Lovastatin—coronary artery disease	0.000154	0.000977	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Lovastatin—coronary artery disease	0.000154	0.000976	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Losartan—coronary artery disease	0.000153	0.000974	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Perindopril—coronary artery disease	0.000153	0.000972	CcSEcCtD
Bismuth Subsalicylate—Headache—Lovastatin—coronary artery disease	0.000153	0.000971	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Valsartan—coronary artery disease	0.000153	0.000968	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Ezetimibe—coronary artery disease	0.000152	0.000966	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Olmesartan—coronary artery disease	0.000152	0.000964	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Losartan—coronary artery disease	0.000152	0.000962	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Captopril—coronary artery disease	0.000151	0.000961	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Simvastatin—coronary artery disease	0.000151	0.000958	CcSEcCtD
Bismuth Subsalicylate—Rash—Ezetimibe—coronary artery disease	0.000151	0.000958	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Ezetimibe—coronary artery disease	0.000151	0.000957	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Ramipril—coronary artery disease	0.000151	0.000957	CcSEcCtD
Bismuth Subsalicylate—Headache—Ezetimibe—coronary artery disease	0.00015	0.000952	CcSEcCtD
Bismuth Subsalicylate—Oedema—Ramipril—coronary artery disease	0.00015	0.000949	CcSEcCtD
Bismuth Subsalicylate—Constipation—Losartan—coronary artery disease	0.000149	0.000947	CcSEcCtD
Bismuth Subsalicylate—Pain—Losartan—coronary artery disease	0.000149	0.000947	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Eplerenone—coronary artery disease	0.000149	0.000946	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Furosemide—coronary artery disease	0.000149	0.000945	CcSEcCtD
Bismuth Subsalicylate—Nausea—Fenofibrate—coronary artery disease	0.000148	0.000943	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Niacin—coronary artery disease	0.000148	0.000942	CcSEcCtD
Bismuth Subsalicylate—Rash—Eplerenone—coronary artery disease	0.000148	0.000938	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Perindopril—coronary artery disease	0.000148	0.000938	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Eplerenone—coronary artery disease	0.000148	0.000937	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Valsartan—coronary artery disease	0.000148	0.000936	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Timolol—coronary artery disease	0.000147	0.000936	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Perindopril—coronary artery disease	0.000147	0.000933	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Olmesartan—coronary artery disease	0.000147	0.000932	CcSEcCtD
Bismuth Subsalicylate—Headache—Eplerenone—coronary artery disease	0.000147	0.000932	CcSEcCtD
Bismuth Subsalicylate—Oedema—Timolol—coronary artery disease	0.000146	0.000928	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Pravastatin—coronary artery disease	0.000146	0.000927	CcSEcCtD
Bismuth Subsalicylate—Nausea—Clopidogrel—coronary artery disease	0.000146	0.000927	CcSEcCtD
Bismuth Subsalicylate—Infection—Timolol—coronary artery disease	0.000145	0.000922	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Simvastatin—coronary artery disease	0.000145	0.000921	CcSEcCtD
Bismuth Subsalicylate—Nausea—Lovastatin—coronary artery disease	0.000145	0.00092	CcSEcCtD
Bismuth Subsalicylate—Rash—Simvastatin—coronary artery disease	0.000144	0.000914	CcSEcCtD
Bismuth Subsalicylate—PTGS1—endothelium—coronary artery disease	0.000144	0.0814	CbGeAlD
Bismuth Subsalicylate—Dermatitis—Simvastatin—coronary artery disease	0.000144	0.000913	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Losartan—coronary artery disease	0.000144	0.000912	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Furosemide—coronary artery disease	0.000144	0.000911	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Niacin—coronary artery disease	0.000143	0.000911	CcSEcCtD
Bismuth Subsalicylate—Headache—Simvastatin—coronary artery disease	0.000143	0.000908	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Furosemide—coronary artery disease	0.000143	0.000907	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Valsartan—coronary artery disease	0.000143	0.000905	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Ramipril—coronary artery disease	0.000143	0.000905	CcSEcCtD
Bismuth Subsalicylate—Nausea—Ezetimibe—coronary artery disease	0.000142	0.000903	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Olmesartan—coronary artery disease	0.000142	0.000901	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Trandolapril—coronary artery disease	0.000142	0.0009	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Enalapril—coronary artery disease	0.000141	0.000897	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Pravastatin—coronary artery disease	0.000141	0.000897	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Timolol—coronary artery disease	0.000139	0.000884	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Telmisartan—coronary artery disease	0.000139	0.000884	CcSEcCtD
Bismuth Subsalicylate—Nausea—Eplerenone—coronary artery disease	0.000139	0.000884	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Niacin—coronary artery disease	0.000139	0.00088	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Losartan—coronary artery disease	0.000139	0.000879	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Losartan—coronary artery disease	0.000138	0.000875	CcSEcCtD
Bismuth Subsalicylate—PTGS2—endothelium—coronary artery disease	0.000137	0.0778	CbGeAlD
Bismuth Subsalicylate—Diarrhoea—Trandolapril—coronary artery disease	0.000137	0.000871	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Valsartan—coronary artery disease	0.000137	0.00087	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Lisinopril—coronary artery disease	0.000137	0.000868	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Enalapril—coronary artery disease	0.000137	0.000867	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Pravastatin—coronary artery disease	0.000136	0.000866	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Olmesartan—coronary artery disease	0.000136	0.000866	CcSEcCtD
Bismuth Subsalicylate—Rash—Valsartan—coronary artery disease	0.000136	0.000863	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Valsartan—coronary artery disease	0.000136	0.000862	CcSEcCtD
Bismuth Subsalicylate—Nausea—Simvastatin—coronary artery disease	0.000136	0.000861	CcSEcCtD
Bismuth Subsalicylate—Oedema—Lisinopril—coronary artery disease	0.000136	0.000861	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Captopril—coronary artery disease	0.000135	0.00086	CcSEcCtD
Bismuth Subsalicylate—Rash—Olmesartan—coronary artery disease	0.000135	0.000859	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Olmesartan—coronary artery disease	0.000135	0.000858	CcSEcCtD
Bismuth Subsalicylate—Headache—Valsartan—coronary artery disease	0.000135	0.000857	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Telmisartan—coronary artery disease	0.000135	0.000855	CcSEcCtD
Bismuth Subsalicylate—Infection—Lisinopril—coronary artery disease	0.000135	0.000855	CcSEcCtD
Bismuth Subsalicylate—Headache—Olmesartan—coronary artery disease	0.000134	0.000853	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Niacin—coronary artery disease	0.000133	0.000846	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Ramipril—coronary artery disease	0.000133	0.000844	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Trandolapril—coronary artery disease	0.000133	0.000841	CcSEcCtD
Bismuth Subsalicylate—Rash—Niacin—coronary artery disease	0.000132	0.000839	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Niacin—coronary artery disease	0.000132	0.000838	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Enalapril—coronary artery disease	0.000132	0.000838	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Ramipril—coronary artery disease	0.000132	0.000835	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Perindopril—coronary artery disease	0.000132	0.000835	CcSEcCtD
Bismuth Subsalicylate—Headache—Niacin—coronary artery disease	0.000131	0.000834	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Pravastatin—coronary artery disease	0.000131	0.000833	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Captopril—coronary artery disease	0.000131	0.000832	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Telmisartan—coronary artery disease	0.00013	0.000827	CcSEcCtD
Bismuth Subsalicylate—Rash—Pravastatin—coronary artery disease	0.00013	0.000826	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Pravastatin—coronary artery disease	0.00013	0.000825	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Ramipril—coronary artery disease	0.00013	0.000825	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Timolol—coronary artery disease	0.00013	0.000825	CcSEcCtD
Bismuth Subsalicylate—Headache—Pravastatin—coronary artery disease	0.000129	0.000821	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Lisinopril—coronary artery disease	0.000129	0.000821	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Timolol—coronary artery disease	0.000129	0.000817	CcSEcCtD
Bismuth Subsalicylate—Nausea—Valsartan—coronary artery disease	0.000128	0.000813	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Furosemide—coronary artery disease	0.000128	0.000812	CcSEcCtD
Bismuth Subsalicylate—Constipation—Ramipril—coronary artery disease	0.000128	0.000812	CcSEcCtD
Bismuth Subsalicylate—Nausea—Olmesartan—coronary artery disease	0.000127	0.000809	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Trandolapril—coronary artery disease	0.000127	0.000809	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Perindopril—coronary artery disease	0.000127	0.000807	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Timolol—coronary artery disease	0.000127	0.000807	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Enalapril—coronary artery disease	0.000127	0.000806	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Captopril—coronary artery disease	0.000127	0.000804	CcSEcCtD
Bismuth Subsalicylate—Rash—Trandolapril—coronary artery disease	0.000126	0.000802	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Trandolapril—coronary artery disease	0.000126	0.000802	CcSEcCtD
Bismuth Subsalicylate—Rash—Enalapril—coronary artery disease	0.000126	0.000799	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Enalapril—coronary artery disease	0.000126	0.000798	CcSEcCtD
Bismuth Subsalicylate—Headache—Trandolapril—coronary artery disease	0.000126	0.000797	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Telmisartan—coronary artery disease	0.000125	0.000795	CcSEcCtD
Bismuth Subsalicylate—Headache—Enalapril—coronary artery disease	0.000125	0.000794	CcSEcCtD
Bismuth Subsalicylate—Pain—Timolol—coronary artery disease	0.000125	0.000793	CcSEcCtD
Bismuth Subsalicylate—Nausea—Niacin—coronary artery disease	0.000125	0.00079	CcSEcCtD
Bismuth Subsalicylate—Rash—Telmisartan—coronary artery disease	0.000124	0.000788	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Telmisartan—coronary artery disease	0.000124	0.000787	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Furosemide—coronary artery disease	0.000124	0.000785	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Losartan—coronary artery disease	0.000123	0.000783	CcSEcCtD
Bismuth Subsalicylate—Headache—Telmisartan—coronary artery disease	0.000123	0.000783	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Ramipril—coronary artery disease	0.000123	0.000782	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Perindopril—coronary artery disease	0.000123	0.00078	CcSEcCtD
Bismuth Subsalicylate—Nausea—Pravastatin—coronary artery disease	0.000123	0.000778	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Captopril—coronary artery disease	0.000122	0.000773	CcSEcCtD
Bismuth Subsalicylate—Rash—Captopril—coronary artery disease	0.000121	0.000766	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Captopril—coronary artery disease	0.000121	0.000766	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Lisinopril—coronary artery disease	0.000121	0.000765	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Timolol—coronary artery disease	0.00012	0.000765	CcSEcCtD
Bismuth Subsalicylate—Headache—Captopril—coronary artery disease	0.00012	0.000761	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Furosemide—coronary artery disease	0.00012	0.000759	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Lisinopril—coronary artery disease	0.000119	0.000758	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Losartan—coronary artery disease	0.000119	0.000757	CcSEcCtD
Bismuth Subsalicylate—Nausea—Trandolapril—coronary artery disease	0.000119	0.000756	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Ramipril—coronary artery disease	0.000119	0.000754	CcSEcCtD
Bismuth Subsalicylate—Nausea—Enalapril—coronary artery disease	0.000119	0.000753	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Perindopril—coronary artery disease	0.000118	0.00075	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Ramipril—coronary artery disease	0.000118	0.00075	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Lisinopril—coronary artery disease	0.000118	0.000748	CcSEcCtD
Bismuth Subsalicylate—Rash—Perindopril—coronary artery disease	0.000117	0.000744	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Perindopril—coronary artery disease	0.000117	0.000743	CcSEcCtD
Bismuth Subsalicylate—Nausea—Telmisartan—coronary artery disease	0.000117	0.000742	CcSEcCtD
Bismuth Subsalicylate—Headache—Perindopril—coronary artery disease	0.000116	0.000739	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Timolol—coronary artery disease	0.000116	0.000737	CcSEcCtD
Bismuth Subsalicylate—Pain—Lisinopril—coronary artery disease	0.000116	0.000736	CcSEcCtD
Bismuth Subsalicylate—Constipation—Lisinopril—coronary artery disease	0.000116	0.000736	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Timolol—coronary artery disease	0.000116	0.000734	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Losartan—coronary artery disease	0.000115	0.000732	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Furosemide—coronary artery disease	0.000115	0.000729	CcSEcCtD
Bismuth Subsalicylate—Rash—Furosemide—coronary artery disease	0.000114	0.000723	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Furosemide—coronary artery disease	0.000114	0.000723	CcSEcCtD
Bismuth Subsalicylate—Nausea—Captopril—coronary artery disease	0.000114	0.000722	CcSEcCtD
Bismuth Subsalicylate—Headache—Furosemide—coronary artery disease	0.000113	0.000719	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Lisinopril—coronary artery disease	0.000112	0.000709	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Losartan—coronary artery disease	0.000111	0.000704	CcSEcCtD
Bismuth Subsalicylate—Nausea—Perindopril—coronary artery disease	0.00011	0.000701	CcSEcCtD
Bismuth Subsalicylate—ALB—heart—coronary artery disease	0.00011	0.0623	CbGeAlD
Bismuth Subsalicylate—Rash—Losartan—coronary artery disease	0.00011	0.000698	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Losartan—coronary artery disease	0.00011	0.000697	CcSEcCtD
Bismuth Subsalicylate—Headache—Losartan—coronary artery disease	0.000109	0.000693	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Lisinopril—coronary artery disease	0.000108	0.000684	CcSEcCtD
Bismuth Subsalicylate—Nausea—Furosemide—coronary artery disease	0.000107	0.000681	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Lisinopril—coronary artery disease	0.000107	0.00068	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Ramipril—coronary artery disease	0.000106	0.000672	CcSEcCtD
Bismuth Subsalicylate—Nausea—Losartan—coronary artery disease	0.000104	0.000657	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Timolol—coronary artery disease	0.000103	0.000656	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Ramipril—coronary artery disease	0.000102	0.000649	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Timolol—coronary artery disease	0.0001	0.000635	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Ramipril—coronary artery disease	9.89e-05	0.000628	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Timolol—coronary artery disease	9.67e-05	0.000614	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Lisinopril—coronary artery disease	9.59e-05	0.000609	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Ramipril—coronary artery disease	9.51e-05	0.000603	CcSEcCtD
Bismuth Subsalicylate—Rash—Ramipril—coronary artery disease	9.43e-05	0.000598	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Ramipril—coronary artery disease	9.42e-05	0.000598	CcSEcCtD
Bismuth Subsalicylate—Headache—Ramipril—coronary artery disease	9.37e-05	0.000595	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Timolol—coronary artery disease	9.29e-05	0.00059	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Lisinopril—coronary artery disease	9.28e-05	0.000589	CcSEcCtD
Bismuth Subsalicylate—Rash—Timolol—coronary artery disease	9.22e-05	0.000585	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Timolol—coronary artery disease	9.21e-05	0.000585	CcSEcCtD
Bismuth Subsalicylate—Headache—Timolol—coronary artery disease	9.16e-05	0.000581	CcSEcCtD
Bismuth Subsalicylate—PTGS1—myocardium—coronary artery disease	8.99e-05	0.0508	CbGeAlD
Bismuth Subsalicylate—Dizziness—Lisinopril—coronary artery disease	8.97e-05	0.000569	CcSEcCtD
Bismuth Subsalicylate—Nausea—Ramipril—coronary artery disease	8.88e-05	0.000564	CcSEcCtD
Bismuth Subsalicylate—Nausea—Timolol—coronary artery disease	8.68e-05	0.000551	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Lisinopril—coronary artery disease	8.62e-05	0.000547	CcSEcCtD
Bismuth Subsalicylate—Rash—Lisinopril—coronary artery disease	8.55e-05	0.000543	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Lisinopril—coronary artery disease	8.54e-05	0.000542	CcSEcCtD
Bismuth Subsalicylate—Headache—Lisinopril—coronary artery disease	8.49e-05	0.000539	CcSEcCtD
Bismuth Subsalicylate—Nausea—Lisinopril—coronary artery disease	8.05e-05	0.000511	CcSEcCtD
Bismuth Subsalicylate—PTGS1—heart—coronary artery disease	6.27e-05	0.0355	CbGeAlD
Bismuth Subsalicylate—PTGS2—heart—coronary artery disease	5.99e-05	0.0339	CbGeAlD
Bismuth Subsalicylate—PTGS1—cardiovascular system—coronary artery disease	5.92e-05	0.0335	CbGeAlD
Bismuth Subsalicylate—PTGS2—cardiovascular system—coronary artery disease	5.66e-05	0.032	CbGeAlD
Bismuth Subsalicylate—PTGS1—cardiac atrium—coronary artery disease	5.36e-05	0.0304	CbGeAlD
Bismuth Subsalicylate—PTGS1—blood—coronary artery disease	4.68e-05	0.0265	CbGeAlD
Bismuth Subsalicylate—PTGS2—blood—coronary artery disease	4.47e-05	0.0253	CbGeAlD
Bismuth Subsalicylate—PTGS1—Metabolism—PIK3C2A—coronary artery disease	1.2e-05	8.87e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—DCN—coronary artery disease	1.2e-05	8.87e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—LPA—coronary artery disease	1.2e-05	8.87e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—APOC3—coronary artery disease	1.19e-05	8.82e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—PLG—coronary artery disease	1.19e-05	8.8e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—LDLR—coronary artery disease	1.18e-05	8.76e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	1.18e-05	8.75e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—HGF—coronary artery disease	1.18e-05	8.74e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—APOA4—coronary artery disease	1.18e-05	8.73e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—SLC9A1—coronary artery disease	1.17e-05	8.66e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GSTT1—coronary artery disease	1.17e-05	8.66e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—CSF2—coronary artery disease	1.17e-05	8.64e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PLCB3—coronary artery disease	1.16e-05	8.59e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	1.16e-05	8.58e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GCLC—coronary artery disease	1.16e-05	8.56e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CETP—coronary artery disease	1.16e-05	8.56e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—APOA5—coronary artery disease	1.15e-05	8.5e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—SDC1—coronary artery disease	1.14e-05	8.46e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PDHA1—coronary artery disease	1.14e-05	8.44e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GCLM—coronary artery disease	1.14e-05	8.44e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—APOC3—coronary artery disease	1.13e-05	8.36e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—P4HB—coronary artery disease	1.13e-05	8.34e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—LDLR—coronary artery disease	1.12e-05	8.31e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—ITGB3—coronary artery disease	1.12e-05	8.28e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	1.11e-05	8.26e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SLC9A1—coronary artery disease	1.11e-05	8.21e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PLA2G1B—coronary artery disease	1.1e-05	8.18e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	1.1e-05	8.18e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP11B2—coronary artery disease	1.1e-05	8.17e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—TXNRD1—coronary artery disease	1.1e-05	8.17e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—coronary artery disease	1.1e-05	8.17e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—CD36—coronary artery disease	1.1e-05	8.15e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—HMOX1—coronary artery disease	1.1e-05	8.12e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	1.09e-05	8.09e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SLC22A3—coronary artery disease	1.09e-05	8.05e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PPP2CA—coronary artery disease	1.09e-05	8.05e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SDC1—coronary artery disease	1.08e-05	8.02e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	1.08e-05	8e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PSMA6—coronary artery disease	1.08e-05	8e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PSMB5—coronary artery disease	1.08e-05	8e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	1.08e-05	7.98e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ARNTL—coronary artery disease	1.07e-05	7.93e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—HADH—coronary artery disease	1.07e-05	7.93e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PRKCD—coronary artery disease	1.07e-05	7.9e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CTGF—coronary artery disease	1.05e-05	7.81e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	1.05e-05	7.81e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—APOB—coronary artery disease	1.05e-05	7.78e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—HMGCR—coronary artery disease	1.04e-05	7.74e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GOT2—coronary artery disease	1.04e-05	7.74e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—VCAN—coronary artery disease	1.04e-05	7.71e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ALDOA—coronary artery disease	1.03e-05	7.65e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	1.03e-05	7.62e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PSMB5—coronary artery disease	1.02e-05	7.58e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PSMA6—coronary artery disease	1.02e-05	7.58e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—VEGFA—coronary artery disease	1.02e-05	7.53e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—APOA2—coronary artery disease	1.01e-05	7.52e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PLA2G2A—coronary artery disease	1.01e-05	7.52e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GPX2—coronary artery disease	1.01e-05	7.52e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—DCN—coronary artery disease	1e-05	7.43e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—MMP1—coronary artery disease	1e-05	7.43e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ABCG5—coronary artery disease	1e-05	7.43e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GPX4—coronary artery disease	1e-05	7.43e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SULT1A1—coronary artery disease	1e-05	7.43e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—HK1—coronary artery disease	1e-05	7.43e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	1e-05	7.42e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—HADHA—coronary artery disease	9.9e-06	7.34e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—GOT2—coronary artery disease	9.9e-06	7.34e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CYBA—coronary artery disease	9.86e-06	7.31e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PLAU—coronary artery disease	9.84e-06	7.29e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CALR—coronary artery disease	9.82e-06	7.27e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GSTA1—coronary artery disease	9.79e-06	7.25e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ALDH2—coronary artery disease	9.75e-06	7.23e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—LPA—coronary artery disease	9.68e-06	7.17e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PLCB1—coronary artery disease	9.61e-06	7.12e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—APOA1—coronary artery disease	9.59e-06	7.11e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	9.51e-06	7.05e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—LIPC—coronary artery disease	9.51e-06	7.04e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—HBA1—coronary artery disease	9.51e-06	7.04e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP2C19—coronary artery disease	9.51e-06	7.04e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PIK3C2A—coronary artery disease	9.51e-06	7.04e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—APOC3—coronary artery disease	9.45e-06	7e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—MAPK14—coronary artery disease	9.44e-06	7e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	9.42e-06	6.98e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—LDLR—coronary artery disease	9.39e-06	6.96e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	9.38e-06	6.95e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PLCB3—coronary artery disease	9.38e-06	6.95e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—TGFB1—coronary artery disease	9.32e-06	6.91e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ABCA1—coronary artery disease	9.31e-06	6.9e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—APOA5—coronary artery disease	9.28e-06	6.88e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—SLC9A1—coronary artery disease	9.28e-06	6.87e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GSTT1—coronary artery disease	9.28e-06	6.87e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GCLC—coronary artery disease	9.17e-06	6.8e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CETP—coronary artery disease	9.17e-06	6.8e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—FN1—coronary artery disease	9.15e-06	6.78e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—F2—coronary artery disease	9.15e-06	6.78e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—MAPK1—coronary artery disease	9.14e-06	6.78e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—HSPA1A—coronary artery disease	9.14e-06	6.77e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—JUNB—coronary artery disease	9.14e-06	6.77e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—P4HB—coronary artery disease	9.1e-06	6.74e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—SDC1—coronary artery disease	9.07e-06	6.72e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—NOS2—coronary artery disease	9.04e-06	6.7e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GGT1—coronary artery disease	9.02e-06	6.68e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GOT1—coronary artery disease	9.02e-06	6.68e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	9.02e-06	6.68e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	9e-06	6.67e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PLA2G1B—coronary artery disease	8.93e-06	6.62e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	8.83e-06	6.54e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	8.73e-06	6.47e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PSMA6—coronary artery disease	8.57e-06	6.35e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PSMB5—coronary artery disease	8.57e-06	6.35e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	8.55e-06	6.34e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—GOT1—coronary artery disease	8.55e-06	6.33e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—VCAN—coronary artery disease	8.42e-06	6.24e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CTGF—coronary artery disease	8.37e-06	6.2e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ALDOA—coronary artery disease	8.36e-06	6.19e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—APOA1—coronary artery disease	8.3e-06	6.15e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—HMGCR—coronary artery disease	8.29e-06	6.15e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GOT2—coronary artery disease	8.29e-06	6.15e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—DCN—coronary artery disease	8.11e-06	6.01e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GSTP1—coronary artery disease	8.1e-06	6e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PPARGC1A—coronary artery disease	8.03e-06	5.95e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—IGF1—coronary artery disease	8.02e-06	5.94e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—HMOX1—coronary artery disease	7.99e-06	5.92e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—PIK3CA—coronary artery disease	7.94e-06	5.88e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ALDH2—coronary artery disease	7.89e-06	5.85e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PRKCE—coronary artery disease	7.89e-06	5.84e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CAT—coronary artery disease	7.88e-06	5.84e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	7.69e-06	5.7e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—HBA1—coronary artery disease	7.69e-06	5.7e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—LIPC—coronary artery disease	7.69e-06	5.7e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP2C19—coronary artery disease	7.69e-06	5.7e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PIK3C2A—coronary artery disease	7.69e-06	5.7e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—KITLG—coronary artery disease	7.68e-06	5.69e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TGFBR2—coronary artery disease	7.68e-06	5.69e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—APOB—coronary artery disease	7.65e-06	5.67e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—APOC3—coronary artery disease	7.64e-06	5.66e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PLCB1—coronary artery disease	7.63e-06	5.65e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—SERPINE1—coronary artery disease	7.61e-06	5.64e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—LDLR—coronary artery disease	7.6e-06	5.63e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	7.59e-06	5.62e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SLC9A1—coronary artery disease	7.51e-06	5.56e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GSTT1—coronary artery disease	7.51e-06	5.56e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—STAT5A—coronary artery disease	7.51e-06	5.56e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GSTM1—coronary artery disease	7.44e-06	5.52e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GCLC—coronary artery disease	7.42e-06	5.5e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CETP—coronary artery disease	7.42e-06	5.5e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ABCA1—coronary artery disease	7.39e-06	5.48e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SDC1—coronary artery disease	7.34e-06	5.44e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—LPL—coronary artery disease	7.31e-06	5.41e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—NOS3—coronary artery disease	7.27e-06	5.39e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—APOB—coronary artery disease	7.25e-06	5.37e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GGT1—coronary artery disease	7.16e-06	5.3e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GOT1—coronary artery disease	7.16e-06	5.3e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GPX1—coronary artery disease	7.13e-06	5.28e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—JAK2—coronary artery disease	7.06e-06	5.23e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—FGF1—coronary artery disease	6.98e-06	5.17e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CD36—coronary artery disease	6.94e-06	5.14e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PSMA6—coronary artery disease	6.93e-06	5.14e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PSMB5—coronary artery disease	6.93e-06	5.14e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—LPL—coronary artery disease	6.93e-06	5.13e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PPP2CA—coronary artery disease	6.86e-06	5.08e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CTGF—coronary artery disease	6.77e-06	5.02e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—HMGCR—coronary artery disease	6.71e-06	4.97e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GOT2—coronary artery disease	6.71e-06	4.97e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—MTHFR—coronary artery disease	6.58e-06	4.87e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PPP2CA—coronary artery disease	6.5e-06	4.82e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—AKT1—coronary artery disease	6.48e-06	4.8e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GSTP1—coronary artery disease	6.43e-06	4.76e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PRKCD—coronary artery disease	6.38e-06	4.73e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PPARGC1A—coronary artery disease	6.37e-06	4.72e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—HMOX1—coronary artery disease	6.34e-06	4.7e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CAT—coronary artery disease	6.26e-06	4.64e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—AGT—coronary artery disease	6.25e-06	4.63e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MTHFR—coronary artery disease	6.24e-06	4.62e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PLCB1—coronary artery disease	6.17e-06	4.57e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—APOE—coronary artery disease	6.13e-06	4.54e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—APOB—coronary artery disease	6.08e-06	4.5e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—APOA1—coronary artery disease	6.05e-06	4.49e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	6.05e-06	4.48e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ABCA1—coronary artery disease	5.98e-06	4.43e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—HIF1A—coronary artery disease	5.95e-06	4.41e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GSTM1—coronary artery disease	5.91e-06	4.38e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—APOE—coronary artery disease	5.81e-06	4.3e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—LPL—coronary artery disease	5.8e-06	4.3e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	5.8e-06	4.3e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GOT1—coronary artery disease	5.79e-06	4.29e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GGT1—coronary artery disease	5.79e-06	4.29e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—APOA1—coronary artery disease	5.74e-06	4.25e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GPX1—coronary artery disease	5.66e-06	4.19e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CD36—coronary artery disease	5.51e-06	4.08e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—IL6ST—coronary artery disease	5.45e-06	4.04e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PPP2CA—coronary artery disease	5.44e-06	4.03e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NOS2—coronary artery disease	5.41e-06	4.01e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PPARG—coronary artery disease	5.34e-06	3.95e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—POMC—coronary artery disease	5.26e-06	3.9e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—KIT—coronary artery disease	5.24e-06	3.88e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—VEGFA—coronary artery disease	5.24e-06	3.88e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—MTHFR—coronary artery disease	5.22e-06	3.87e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GSTP1—coronary artery disease	5.2e-06	3.85e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PPARGC1A—coronary artery disease	5.15e-06	3.82e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—HMOX1—coronary artery disease	5.13e-06	3.8e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CAT—coronary artery disease	5.06e-06	3.75e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—GSK3B—coronary artery disease	5.03e-06	3.73e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CREB1—coronary artery disease	4.99e-06	3.7e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—AGT—coronary artery disease	4.96e-06	3.68e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—APOB—coronary artery disease	4.92e-06	3.64e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—IL6R—coronary artery disease	4.87e-06	3.6e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—APOE—coronary artery disease	4.86e-06	3.6e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—APOA1—coronary artery disease	4.81e-06	3.56e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—TGFB1—coronary artery disease	4.81e-06	3.56e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ALB—coronary artery disease	4.8e-06	3.55e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GSTM1—coronary artery disease	4.78e-06	3.54e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—MAPK1—coronary artery disease	4.71e-06	3.49e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—LPL—coronary artery disease	4.69e-06	3.48e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	4.6e-06	3.41e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—NOS3—coronary artery disease	4.59e-06	3.4e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GPX1—coronary artery disease	4.58e-06	3.39e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SERPINE1—coronary artery disease	4.56e-06	3.38e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CD36—coronary artery disease	4.46e-06	3.3e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—FGF2—coronary artery disease	4.41e-06	3.27e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PPP2CA—coronary artery disease	4.4e-06	3.26e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NOS3—coronary artery disease	4.35e-06	3.22e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PPARG—coronary artery disease	4.24e-06	3.14e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—JAK2—coronary artery disease	4.23e-06	3.13e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—MTHFR—coronary artery disease	4.23e-06	3.13e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PTGS2—coronary artery disease	4.2e-06	3.11e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—POMC—coronary artery disease	4.18e-06	3.09e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PIK3CA—coronary artery disease	4.09e-06	3.03e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—AGT—coronary artery disease	4.01e-06	2.97e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—APOE—coronary artery disease	3.93e-06	2.91e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—APOA1—coronary artery disease	3.89e-06	2.88e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ALB—coronary artery disease	3.81e-06	2.82e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.72e-06	2.76e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—NOS3—coronary artery disease	3.64e-06	2.7e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PPARG—coronary artery disease	3.43e-06	2.54e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—POMC—coronary artery disease	3.38e-06	2.5e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—AKT1—coronary artery disease	3.34e-06	2.48e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—NOS3—coronary artery disease	2.95e-06	2.18e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TGFB1—coronary artery disease	2.88e-06	2.13e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MAPK1—coronary artery disease	2.82e-06	2.09e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PTGS2—coronary artery disease	2.7e-06	2e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PIK3CA—coronary artery disease	2.58e-06	1.91e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PIK3CA—coronary artery disease	2.45e-06	1.81e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—IL6—coronary artery disease	2.17e-06	1.61e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—AKT1—coronary artery disease	2.11e-06	1.56e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PIK3CA—coronary artery disease	2.05e-06	1.52e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—AKT1—coronary artery disease	2e-06	1.48e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—AKT1—coronary artery disease	1.67e-06	1.24e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PIK3CA—coronary artery disease	1.66e-06	1.23e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—AKT1—coronary artery disease	1.35e-06	1e-05	CbGpPWpGaD
